These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6182404)

  • 1. PGI2 prevents ischemia-induced alterations in cardiac catecholamines without influencing nerve-stimulation-induced catecholamine release in nonischemic conditions.
    Schrör K; Darius H; Addicks K; Köster R; Smith EF
    J Cardiovasc Pharmacol; 1982; 4(5):741-8. PubMed ID: 6182404
    [No Abstract]   [Full Text] [Related]  

  • 2. PGI2 inhibits ischemia-induced platelet activation and prevents myocardial damage by inhibition of catecholamine release from adrenergic nerve terminals. Evidence for cAMP as common denominator.
    Schrör K; Addicks K; Darius H; Ohlendorf R; Rösen P
    Thromb Res; 1981 Jan 1-15; 21(1-2):175-80. PubMed ID: 6262944
    [No Abstract]   [Full Text] [Related]  

  • 3. Catecholamines in myocardial ischemia. Systemic and cardiac release.
    Schömig A
    Circulation; 1990 Sep; 82(3 Suppl):II13-22. PubMed ID: 2203558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin-induced changes in coronary blood flow and oxygen handling in the normal and acutely ischaemic canine myocardium.
    Coker SJ; Parratt JR
    Basic Res Cardiol; 1981; 76(4):457-62. PubMed ID: 7025832
    [No Abstract]   [Full Text] [Related]  

  • 5. Endogenous prostacyclin preserves myocardial function and endothelium-derived nitric oxide formation in myocardial ischemia.
    Schrör K; Woditsch I
    Agents Actions Suppl; 1992; 37():312-9. PubMed ID: 1632306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of catecholamines in the ischemic zone of the dog heart.
    Muntz KH; Hagler HK; Boulas HJ; Willerson JT; Buja LM
    Am J Pathol; 1984 Jan; 114(1):64-78. PubMed ID: 6691416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin prevents ischemia-induced increase of lactate and cyclic AMP in ischemic myocardium.
    Rösen R; Rösen P; Ohlendorf R; Schrör K
    Eur J Pharmacol; 1981 Feb; 69(4):489-91. PubMed ID: 6265230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathology of ischemic heart disease].
    Scheidler K; Weser C; Müller JH
    Z Arztl Fortbild (Jena); 1974 Jun; 68(12):610-5. PubMed ID: 4547892
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible role of prostaglandins in the regulation of coronary blood flow.
    Schrör K
    Basic Res Cardiol; 1981; 76(3):239-49. PubMed ID: 6268056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of cardiac hemodynamics and metabolism in normal and coronary patients].
    Rocher R; Fayard JM; Manin JP; Guermonprez JL; Schlumberger JF; Vagner D; Leclerc M; Ourbak P; Maurice P
    Arch Mal Coeur Vaiss; 1974 Sep; 67(9):997-1006. PubMed ID: 4215393
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart.
    Kowey PR; Verrier RL; Lown B
    Eur J Pharmacol; 1982 May; 80(1):83-91. PubMed ID: 7047179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and metabolic effects of prostacyclin after coronary bypass surgery.
    Chelly J; Fabiani JN; Chahine R; Tricot AM; Carpentier A; Passelecq J; Dubost C
    Circulation; 1982 Aug; 66(2 Pt 2):I45-9. PubMed ID: 7044613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of beraprost, a prostacyclin-mimetic agent, on post-hypoxic recovery of cardiac function and metabolism in rabbit isolated hearts.
    Tanonaka K; Maruyama Y; Takeo S
    Br J Pharmacol; 1991 Dec; 104(4):779-86. PubMed ID: 1810595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged protective effect of propranolol on hypoxic heart muscle.
    Nayler WG; Yepez CE; Fassold E; Ferrari R
    Am J Cardiol; 1978 Aug; 42(2):217-25. PubMed ID: 685835
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of catecholamine effects on canine myocardial metabolism and regional blood flow during and after cardiopulmonary bypass.
    Ward HB; Einzig S; Wang T; Bianco RW; Foker JE
    J Thorac Cardiovasc Surg; 1984 Mar; 87(3):452-65. PubMed ID: 6700252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of catecholamine on reperfused myocardium following hypothermic global ischemia].
    Ozeki M
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):401-8. PubMed ID: 6749111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing infarct size following coronary artery occlusion.
    Kjekshus JK
    J Oslo City Hosp; 1974; 24(11-12):155-75. PubMed ID: 4615137
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood pressure and cardiac tissue responses to prostacyclin (PGI2) in various species.
    Collins GA; MacLeod BA; Walker MJ
    Can J Physiol Pharmacol; 1982 Feb; 60(2):134-9. PubMed ID: 6282426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors.
    Xiao CY; Hara A; Yuhki K; Fujino T; Ma H; Okada Y; Takahata O; Yamada T; Murata T; Narumiya S; Ushikubi F
    Circulation; 2001 Oct; 104(18):2210-5. PubMed ID: 11684633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.